Register
Ivermectin + diethylcarbamazine + albendazole clears microfilaremia in lymphatic filariasis |
Journal Updates
eMediNexus Coverage from: 
Ivermectin + diethylcarbamazine + albendazole clears microfilaremia in lymphatic filariasis
eMediNexus,  11 November 2018
remove_red_eye 863 Views
#Dermatology #Hospital Medicine #Infectious Diseases

3 Read Comments                

In a randomized, controlled trial involving adults from Papua New Guinea with Wuchereria bancrofti microfilaremia, the three-drug regimen of ivermectin + diethylcarbamazine + albendazole induced clearance of microfilariae from the blood for 3 years in almost all participants who received the treatment and was superior to the two-drug regimen of diethylcarbamazine + albendazole administered once and noninferior to the two-drug regimen administered once a year for 3 years. These findings are published in the New England Journal of Medicine, Nov. 8, 2018.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now